Orca Therapeutics
ORCA Therapeutics B.V. is a privately-funded biopharmaceutical company designing and developing new oncolytic immunotherapies for treatment of cancer using Oncolytic Replication Competent Agents (ORCA). At ORCA we are passionate about using viruses to cure cancer patients. Our proprietary technologies allow us to engineer powerful oncolytic adenoviruses that selectively kill cancer cells and induce an antitumor immune response. ORCA’s lead compound ORCA-010 is being developed for treatment naive patients with prostate cancer. For more information, please visit
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Orca Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Orca Therapeutics
3 distinct titles indexed · top 3 shown.
- 1member of the supervisory board
- 1researcher
- 1translational and clinical biomarker scientist
Sign up to unlock all 4 contacts at Orca Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Orca Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.